Ionis Pharmaceuticals Inc. Common Stock vs Teradata Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 2.5× Teradata Corporation Common Stock's market cap, and Teradata Corporation Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Teradata Corporation Common Stock for 0 Days on average.
| IONS | TDC | |
|---|---|---|
Market Cap | $7.04B | $2.83B |
Volume | 2,977,440 | 1,343,944 |
Sector | Health | Technology |
52-Week High | $86.50 | $37.88 |
52-Week Low | $42.38 | $20.71 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $2.52B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →